ArticleNMR in biomedicine2019

Longitudinal preclinical magnetic resonance imaging of diffuse tumor burden in intramedullary myeloma following bortezomib therapy.

Deep K Hathi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.